Advertisement - Members don't see this ad
Ceftobiprole, the fifth generation cephalosporin which covers MRSA and Pseudomonas. Good candidate for monotherapy...but will also break the hospital antibiotic budget if not controlled.
Basilea Pharmaceutical, a swiss company's stock has tripled in the past 3 or so years... the drug will be comarketed with Johnson and Johnson..which means your favorite Levaquin reps are salivating today...
J&J will probably assasinate me.. because I'll make sure this drug is not added to any formulary..anwhere...while getting Levaquin off the formulary.
Basilea Pharmaceutical, a swiss company's stock has tripled in the past 3 or so years... the drug will be comarketed with Johnson and Johnson..which means your favorite Levaquin reps are salivating today...
J&J will probably assasinate me.. because I'll make sure this drug is not added to any formulary..anwhere...while getting Levaquin off the formulary.